Navigation Links
ABX CROSSROADS Advances Discussion, Call to Action Regarding Antibiotic Resistance
Date:11/2/2015

NASHVILLE, Tenn., Nov. 2, 2015 /PRNewswire/ -- In response to the growing  number of international news stories about antibiotic resistance and bacterial superbugs, Diatherix Laboratories and Thermo Fisher Scientific will convene ABX CROSSROADS, a national symposium to explore the clinical, financial and operational challenges facing healthcare providers in the "post-antibiotic era."

ABX CROSSROADS will assemble a national audience of pharmacists, hospitalists, infection control specialists and healthcare administrators on Nov. 6, at the Hutton Hotel in Nashville. The day-long symposium is designed to help participants share knowledge, learn best practices and advance the national dialogue on antimicrobial stewardship.

"The alarming speed of the antibiotic resistance crisis is clearly outpacing conventional thinking," said Chris Linthwaite, president of genetic sciences at Thermo Fisher Scientific. "Only through a focused, national dialogue that is supported by innovative thinking and collaboration will we be able to explore new strategies to address this global threat to human health."

James Michael Keegan, M.D., Principal and Service Line Leader for Antibiotic Stewardship at Pershing Yoakley & Associates, will serve as moderator for ABX CROSSROADS, facilitating several industry thought leaders through a day long discussion:

Ed Septimus, M.D., FIDSA, FACP, FSHEA, Medical Director Infection Prevention and Epidemiology Clinical Services Group at HCA Healthcare System, will discuss the Crisis of Antimicrobial Resistance and deliver a call to action for healthcare providers worldwide.

Ronald Wyatt, M.D., M.H.A., Medical Director of Healthcare Improvement for The Joint Commission will discuss antibiotics and Patient Safety in the Context of Quality Improvement.

A discussion on Antimicrobial Stewardship in the Age of Pay for Performance and Patient Centered Care will be led by Keith S. Kaye, M.D., M.P.H., FIDSA, FACP, FSHEA, Medical Director of Hospital Epidemiology and Antimicrobial Stewardship Detroit Medical Center and Professor of Medicine at Wayne State University.

Kenneth P. Klinker, PharmD, Clinical Specialist in Infectious Diseases with University of Florida Shands Hospital, will provide financial and operational considerations in his discussion of Quantifying Antimicrobial Stewardship Results for the C-Suite.

Kavita K. Trivedi, M.D., principal and founder of Trivedi Consultants, LLC, will discuss Coordinating Patient Care Beyond the Acute Care Setting.

Senior Vice President of Physician Services and Clinical Integration for Catholic Health Initiatives T. Clifford Deveny, M.D., finishes the day discussing with a challenge for participants to become "Change Agents" of antimicrobial stewardship.

To register for ABX CROSSROADS, or to learn more about the event, visit www.ABXCROSSROADS.com.  Become part of the national dialogue on antibiotic resistance by following ABX CROSSROADS on Twitter, LinkedIn, YouTube or Vimeo.

Media Contact:
Leslie Raney
615-297-7766


'/>"/>
SOURCE ABX CROSSROADS
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Vaccines at the Crossroads: Outbreaks On the Rise Across America
2. ABX CROSSROADS to Convene National Dialogue on Antibiotic Resistance in Healthcare
3. Bio-Artificial Pancreas Technology to Cure Diabetes Advances
4. ResMed Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate
5. Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018) -- Technology Trend Analysis -- By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis -- Estimates up to 2018
6. Rheumatology Network Presents Latest Advances Against Baffling Inflammatory Diseases From Major Rheumatology Conference
7. FIU Researcher Advances Retinal Implant That Could Restore Sight For The Blind
8. German Experts Present Medical Imaging Advances at RSNA 13
9. Ventilators Market to 2020 - Technical Advances and Hospital Expansion Serve as Distinct Regional Growth Drivers
10. KemPharm, Inc. Advances KP201 Clinical Program with Initiation of Human Abuse Liability and Human Gastrointestinal Motility Trials
11. TB Alliance Advances Next-Generation TB Drug Candidate into Clinical Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
(Date:5/29/2017)... TEL AVIV, Israel, May 29, 2017  Cellect Biotechnology ... of innovative technology which enables the functional selection of ... financial results for the first quarter ended March 31 ... pleased with our accomplishments in the first quarter of ... the first quarter, we announced the treatment of the ...
(Date:5/23/2017)... 23, 2017  Leaf Healthcare, recognized for developing ... for pressure ulcer prevention, will unveil its comprehensive ... Critical Care Nurses, National Teaching Institute and Critical ... The Leaf Patient Monitoring System is the first ... environment.  The system seamlessly tracks patient movement throughout ...
Breaking Medicine Technology:
(Date:6/22/2017)... ... ... Despite its pervasiveness, many physicians are unfamiliar with how best to treat ... practice. Now, however, a timely review has been published in the Journal of ... NeuP and educating preclinical scientists on its diagnosis and choice of treatment. , The ...
(Date:6/20/2017)... Murfreesboro, Tennessee (PRWEB) , ... June 20, 2017 ... ... chronic care services, announced today that Claritas Capital, a Nashville-based private equity firm, ... to accelerate our expansion plans for some time, and Claritas Capital offers the ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, Inc., ... a new eBook titled “ 5 Questions to Ask Before Entering the Maze ... the Genetic Test Evaluation (GTE) team, the book explores the various types of ...
(Date:6/20/2017)... ... 20, 2017 , ... AMC Health , the leading provider of proven ... trials market. Similar to its approach in demonstrating positive outcomes in the healthcare market, ... proving the value of eVisits to support virtual studies. , In a ...
(Date:6/20/2017)... ... June 20, 2017 , ... With certifications and experience that puts ... NJ, Drs. Adam and Hal Kimowitz are currently accepting new patients at their practice ... can cause for some patients, which is why they offer the latest in modern ...
Breaking Medicine News(10 mins):